Your browser is no longer supported. Please, upgrade your browser.
TMO Thermo Fisher Scientific Inc. monthly Stock Chart
TMO [NYSE]
Thermo Fisher Scientific Inc.
IndexS&P 500 P/E44.74 EPS (ttm)9.31 Insider Own0.10% Shs Outstand395.00M Perf Week0.21%
Market Cap165.36B Forward P/E25.24 EPS next Y16.51 Insider Trans-50.36% Shs Float394.73M Perf Month6.09%
Income3.73B PEG4.05 EPS next Q3.86 Inst Own91.20% Short Float0.79% Perf Quarter23.51%
Sales26.25B P/S6.30 EPS this Y22.10% Inst Trans0.00% Short Ratio2.32 Perf Half Y24.14%
Book/sh75.63 P/B5.51 EPS next Y9.72% ROA6.30% Target Price439.81 Perf Year54.59%
Cash/sh- P/C- EPS next 5Y11.04% ROE12.60% 52W Range250.21 - 423.70 Perf YTD28.24%
Dividend0.88 P/FCF42.09 EPS past 5Y14.30% ROI8.50% 52W High-2.54% Beta1.04
Dividend %0.21% Quick Ratio2.00 Sales past 5Y8.60% Gross Margin45.40% 52W Low65.04% ATR8.66
Employees75000 Current Ratio2.60 Sales Q/Q9.50% Oper. Margin17.00% RSI (14)60.16 Volatility1.85% 1.99%
OptionableYes Debt/Eq0.71 EPS Q/Q4.60% Profit Margin14.10% Rel Volume0.51 Prev Close416.60
ShortableYes LT Debt/Eq0.69 EarningsJul 22 BMO Payout8.50% Avg Volume1.34M Price412.94
Recom1.70 SMA200.49% SMA508.36% SMA20023.67% Volume407,451 Change-0.88%
Jul-15-20Upgrade Cleveland Research Neutral → Buy
Jul-07-20Reiterated Needham Buy $383 → $415
Apr-23-20Reiterated Needham Buy $341 → $383
Jan-31-20Reiterated Needham Buy $331 → $341
Jan-22-20Initiated Credit Suisse Neutral $341
Jan-08-20Initiated Wells Fargo Equal Weight $350
Jan-07-20Initiated Citigroup Buy $380
Nov-15-19Initiated Stifel Buy
Jul-25-19Reiterated Needham Buy $315 → $321
Jul-16-19Downgrade Needham Strong Buy → Buy $315
May-30-19Initiated Wolfe Research Outperform
May-23-19Reiterated Needham Strong Buy $313 → $315
Apr-22-19Reiterated Needham Strong Buy $271 → $312
Apr-16-19Reiterated BofA/Merrill Buy $285 → $300
Jan-03-19Initiated Needham Strong Buy $271
Oct-18-18Downgrade Cleveland Research Buy → Neutral
Oct-09-18Initiated UBS Buy
Sep-24-18Reiterated Barclays Overweight $250 → $275
Sep-17-18Downgrade Goldman Buy → Neutral
Feb-01-18Reiterated Barclays Overweight $225 → $245
Aug-14-20 10:46AM  
07:55AM  
Aug-13-20 01:54PM  
09:39AM  
09:13AM  
08:06AM  
07:41AM  
07:33AM  
07:30AM  
Aug-12-20 04:59PM  
04:47PM  
08:41AM  
07:10AM  
Aug-11-20 10:14AM  
09:23AM  
08:10AM  
Aug-10-20 06:16PM  
08:17AM  
05:43AM  
03:18AM  
Aug-07-20 08:15PM  
12:24PM  
11:30AM  
07:20AM  
Aug-06-20 04:21PM  
11:40AM  
09:27AM  
09:26AM  
09:26AM  
09:24AM  
09:22AM  
09:21AM  
Aug-05-20 09:47AM  
09:37AM  
09:08AM  
08:00AM  
Aug-04-20 05:53PM  
05:39PM  
04:12PM  
12:44PM  
08:14AM  
08:06AM  
Aug-03-20 11:05AM  
08:43AM  
Aug-01-20 07:07AM  
Jul-31-20 12:14PM  
12:13PM  
11:43AM  
Jul-30-20 10:02AM  
09:20AM  
Jul-29-20 07:37AM  
Jul-27-20 09:14AM  
08:54AM  
07:00AM  
Jul-24-20 01:38PM  
10:15AM  
08:33AM  
Jul-23-20 09:46AM  
09:27AM  
Jul-22-20 04:25PM  
02:01PM  
01:24PM  
01:00PM  
11:30AM  
10:58AM  
10:24AM  
09:34AM  
09:04AM  
08:55AM  
07:58AM  
07:30AM  
06:00AM  
05:30AM  
Jul-21-20 09:04AM  
08:45AM  
08:41AM  
Jul-20-20 08:00AM  
06:24AM  
Jul-17-20 11:16AM  
09:48AM  
Jul-16-20 09:50PM  
01:17PM  
10:31AM  
09:01AM  
08:45AM  
Jul-15-20 09:44AM  
Jul-14-20 10:06AM  
09:22AM  
Jul-13-20 08:36AM  
Jul-10-20 01:37PM  
Jul-09-20 05:00PM  
07:04AM  
Jul-07-20 10:21AM  
Jul-06-20 08:00AM  
Jul-03-20 12:38PM  
Jul-02-20 05:37PM  
12:10PM  
10:06AM  
08:11AM  
Jul-01-20 02:10PM  
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; cancer diagnosis and medical research products; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics and chemicals; and pharma services. It has collaboration with WuXi Diagnostics and Mayo Clinic to develop antibodies tests; a strategic collaboration with Schrodinger, Inc. to expand structure-based drug discovery to novel targets using Cryo-EM; and an agreement with Daiichi Sankyo to co-develop a companion diagnostic. The company was incorporated in 1956 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CASPER MARC NChairman & CEOJul 31Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 31Sale409.0220,0008,180,400240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Option Exercise131.0720,0002,621,400260,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 30Sale405.3120,0008,106,200240,446Aug 03 04:32 PM
CASPER MARC NChairman & CEOJul 29Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
Williamson StephenSr. VP and CFOJul 29Option Exercise131.0719,8002,595,18657,789Jul 31 04:03 PM
Williamson StephenSr. VP and CFOJul 29Sale410.8319,8008,134,47137,989Jul 31 04:03 PM
CASPER MARC NChairman & CEOJul 29Sale411.0520,0008,221,015240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Option Exercise131.0720,0002,621,400260,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 28Sale411.6220,0008,232,400240,446Jul 30 07:49 PM
CASPER MARC NChairman & CEOJul 27Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
Jafry Syed A.Sr. Vice PresidentJul 27Option Exercise181.0820,5133,714,47927,219Jul 29 04:09 PM
Jafry Syed A.Sr. Vice PresidentJul 27Sale414.9420,5138,511,64621,019Jul 29 04:09 PM
CASPER MARC NChairman & CEOJul 27Sale404.4020,0008,088,000240,446Jul 28 04:13 PM
Stevenson MarkExecutive Vice President & COOJul 24Option Exercise124.2825,0003,107,00073,621Jul 28 04:06 PM
CASPER MARC NChairman & CEOJul 24Option Exercise131.0720,0002,621,400260,446Jul 28 04:13 PM
CASPER MARC NChairman & CEOJul 24Sale403.3720,0008,067,400240,446Jul 28 04:13 PM
Stevenson MarkExecutive Vice President & COOJul 24Sale404.5825,00010,114,46548,621Jul 28 04:06 PM
MANZI JIM PDirectorJul 24Sale402.383,2181,294,86518,986Jul 28 04:01 PM
CASPER MARC NChairman & CEOJun 02Option Exercise124.2814,7951,838,723289,741Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 02Sale349.5514,7955,171,606274,946Jun 04 04:37 PM
CASPER MARC NChairman & CEOJun 01Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
Williamson StephenSr. VP and CFOJun 01Sale348.002,500870,00037,989Jun 02 04:21 PM
CASPER MARC NChairman & CEOJun 01Sale349.8920,0006,997,718274,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Option Exercise124.2820,0002,485,600294,946Jun 02 04:19 PM
CASPER MARC NChairman & CEOMay 29Sale349.2620,0006,985,200274,946Jun 02 04:19 PM
Stevenson MarkExecutive Vice President & COOMay 18Option Exercise124.2825,0003,107,00073,621May 20 04:47 PM
CASPER MARC NChairman & CEOMay 18Option Exercise124.2816,7052,076,097291,651May 20 05:07 PM
CASPER MARC NChairman & CEOMay 18Sale349.4416,7055,837,472274,946May 20 05:07 PM
Stevenson MarkExecutive Vice President & COOMay 18Sale348.7825,0008,719,57548,621May 20 04:47 PM
CASPER MARC NChairman & CEOApr 28Option Exercise124.2830,0003,728,400304,946Apr 29 04:22 PM
CASPER MARC NChairman & CEOApr 28Sale333.0230,0009,990,609274,946Apr 29 04:22 PM
Stevenson MarkExecutive Vice President & COOApr 24Option Exercise124.2825,0003,107,00073,538Apr 27 06:55 PM
Stevenson MarkExecutive Vice President & COOApr 24Sale328.0325,0008,200,65548,538Apr 27 06:55 PM
Williamson StephenSr. VP and CFOMar 04Option Exercise124.288,7001,081,23649,189Mar 05 04:34 PM
Stevenson MarkExecutive Vice President & COOMar 04Option Exercise124.2825,0003,107,00073,538Mar 05 04:59 PM
Stevenson MarkExecutive Vice President & COOMar 04Sale324.2825,0008,107,00048,538Mar 05 04:59 PM
Williamson StephenSr. VP and CFOMar 04Sale318.548,7002,771,29840,489Mar 05 04:34 PM
Lagarde MichelExecutive Vice PresidentMar 04Sale318.5412,0003,822,48026,385Mar 05 04:28 PM
Lagarde MichelExecutive Vice PresidentMar 03Sale319.8112,0003,837,72038,385Mar 05 04:28 PM
Williamson StephenSr. VP and CFOMar 02Sale291.032,500727,57540,489Mar 04 04:00 PM
CASPER MARC NChief Executive OfficerFeb 11Option Exercise124.2830,0003,728,400278,731Feb 13 04:07 PM
CASPER MARC NChief Executive OfficerFeb 11Sale337.1330,00010,114,048248,731Feb 13 04:07 PM
MANZI JIM PDirectorFeb 05Sale332.324,4101,465,53121,632Feb 06 04:32 PM
Williamson StephenSr. VP and CFOFeb 03Sale319.133,2681,042,91734,402Feb 05 05:59 PM
CASPER MARC NChief Executive OfficerOct 25Option Exercise73.2447,7293,495,672328,960Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerOct 25Sale295.8847,72914,121,958281,231Oct 29 04:42 PM
CASPER MARC NChief Executive OfficerSep 13Option Exercise73.242,271166,328283,502Sep 17 04:54 PM
CASPER MARC NChief Executive OfficerSep 13Sale298.002,271676,758281,231Sep 17 04:54 PM
MANZI JIM PDirectorAug 15Sale272.931,833500,27927,892Aug 19 04:17 PM